3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Osteoporosis
4
Prostatic Neoplasms
3
Breast Neoplasms
3
Vitamin D Deficiency
2
Polycystic Ovary Syndrome
2
Neoplasms
2
Cardiovascular Diseases
2
Vitamin D3
1
Neuroma
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Locally Advanced Breast Cancer and Large Operable Breast Cancer
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Insulin Resistance
1
Fractures, Bone
1
Colorectal Adenocarcinoma
1
Interventions
Ralfinamide
1
Lidoderm
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Neuroma
×
Cholecalciferol
×
Clear all
NCT04115982
2021-08-31
D3NERV
University Hospital, Caen
Phase 3
Unknown
72 enrolled